Recombinant multi-species CaMKII/CAMK2D protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CaMKII/CAMK2D protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The product of this gene belongs to the serine/threonine protein kinase family and to the Ca(2+)/calmodulin-dependent protein kinase subfamily. Calcium signaling is crucial for several aspects of plasticity at glutamatergic synapses. In mammalian cells, the enzyme is composed of four different chains: alpha, beta, gamma, and delta. The product of this gene is a delta chain. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Distinct isoforms of this chain have different expression patterns.[provided by RefSeq, Nov 2008]
The Alternative Names of target: 2810011D23Rik,8030469K03Rik,CAMK1,CAMK2D,CAMKD,CaM kinase II subunit delta,CaMK II,CaMK-II subunit delta,CaMKII,Calcium/calmodulin-dependent protein kinase type II subunit delta,Camk2,Camk2d,Camki,RATCAMKI,[d]-CaMKII

Target products collectionGo to CaMKII/CAMK2D products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0256-Ag-1/ GM-Tg-hg-IP0256-Ag-2 Human CaMKII/CAMK2D protein Human
GM-Tg-rg-IP0256-Ag-1/ GM-Tg-rg-IP0256-Ag-2 Rat CaMKII/CAMK2D protein Rat
GM-Tg-mg-IP0256-Ag-1/ GM-Tg-mg-IP0256-Ag-2 Mouse CaMKII/CAMK2D protein Mouse
GM-Tg-cynog-IP0256-Ag-1/ GM-Tg-cynog-IP0256-Ag-2 Cynomolgus/Rhesus macaque CaMKII/CAMK2D protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0256-Ag-1/ GM-Tg-felg-IP0256-Ag-2 Feline CaMKII/CAMK2D protein Feline
GM-Tg-cang-IP0256-Ag-1/ GM-Tg-cang-IP0256-Ag-2 Canine CaMKII/CAMK2D protein Canine
GM-Tg-bovg-IP0256-Ag-1/ GM-Tg-bovg-IP0256-Ag-2 Bovine CaMKII/CAMK2D protein Bovine
GM-Tg-equg-IP0256-Ag-1/ GM-Tg-equg-IP0256-Ag-2 Equine CaMKII/CAMK2D protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0256-Ag-1/ GM-Tg-hg-IP0256-Ag-2; GM-Tg-rg-IP0256-Ag-1/ GM-Tg-rg-IP0256-Ag-2;
GM-Tg-mg-IP0256-Ag-1/ GM-Tg-mg-IP0256-Ag-2; GM-Tg-cynog-IP0256-Ag-1/ GM-Tg-cynog-IP0256-Ag-2;
GM-Tg-felg-IP0256-Ag-1/ GM-Tg-felg-IP0256-Ag-2; GM-Tg-cang-IP0256-Ag-1/ GM-Tg-cang-IP0256-Ag-2;
GM-Tg-bovg-IP0256-Ag-1/ GM-Tg-bovg-IP0256-Ag-2; GM-Tg-equg-IP0256-Ag-1/ GM-Tg-equg-IP0256-Ag-2
Products Name CaMKII/CAMK2D protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CaMKII/CAMK2D
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CaMKII/CAMK2D protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.